Otsuka America Pharmaceutical, Inc. 02684 X7902684 X7902684 02684
Not Your Device? Search For Manuals or Datasheets below:
File Info : application/pdf, 4 Pages, 14.97KB
Document DEVICE REPORTGetApplicationAttachment.html?id=6462445To: From: William Graff [email protected] Samuel Uganzenwoko [email protected] FCC Equipment Authorization Branch Re: FCC ID: X7902684 Applicant: Correspondence Number: 731 Confirmation Number: Date of Original E-Mail: Otsuka America Pharmaceutical, Inc. 552514 TC174727 04/08/2023 Subject: Attestation letters required Please provide 3 attestation letters(Applicant, Agent and Equipment) with required language signed by both Applicant and Agent, place them in Attestation exhibits folder and not in Cover letter exhibits The items indicated above must be submitted before processing can continue on the above referenced application. Failure to provide the requested information within 30 days of the original e-mail date may result in application dismissal pursuant to Section 2.917(c). DO NOT Reply to this email by using the Reply button. In order for your response to be processed expeditiously, you must upload your response via the Internet at https://apps.fcc.gov/tcb, TCB Login, Submit Correspondence. Also, please note that partial responses increase processing time and should not be submitted. Any questions about the content of this correspondence should be directed to the e-mail address listed below the name of the sender. To: From: David Spencer [email protected] Samuel Uganzenwoko [email protected] FCC Equipment Authorization Branch Re: FCC ID: X7902684 Applicant: Correspondence Number: 731 Confirmation Number: Date of Original E-Mail: Otsuka America Pharmaceutical, Inc. 552517 TC174727 04/08/2023 Subject: Attestation letters required Please provide 3 attestation letters(Applicant, Agent and Equipment) with required language signed by both Applicant and Agent, place them in Attestation exhibits folder and not in Cover letter exhibits The items indicated above must be submitted before processing can continue on the above referenced application. Failure to provide the requested information within 30 days of the original e-mail date may result in application dismissal pursuant to Section 2.917(c). DO NOT Reply to this email by using the Reply button. In order for your response to be processed expeditiously, you must upload your response via the Internet at https://apps.fcc.gov/tcb, TCB Login, Submit Correspondence. Also, please note that partial responses increase processing time and should not be submitted. Any questions about the content of this correspondence should be directed to the e-mail address listed below the name of the sender. To: From: Todd Thompson [email protected] Samuel Uganzenwoko [email protected] FCC Equipment Authorization Branch Re: FCC ID: X7902684 Applicant: Correspondence Number: 731 Confirmation Number: Date of Original E-Mail: Otsuka America Pharmaceutical, Inc. 552516 TC174727 04/08/2023 Subject: Attestation letters required Please provide 3 attestation letters(Applicant, Agent and Equipment) with required language signed by both Applicant and Agent, place them in Attestation exhibits folder and not in Cover letter exhibits The items indicated above must be submitted before processing can continue on the above referenced application. Failure to provide the requested information within 30 days of the original e-mail date may result in application dismissal pursuant to Section 2.917(c). DO NOT Reply to this email by using the Reply button. In order for your response to be processed expeditiously, you must upload your response via the Internet at https://apps.fcc.gov/tcb, TCB Login, Submit Correspondence. Also, please note that partial responses increase processing time and should not be submitted. Any questions about the content of this correspondence should be directed to the e-mail address listed below the name of the sender. To: From: Jim Hutchinson [email protected] Samuel Uganzenwoko [email protected] FCC Equipment Authorization Branch Re: FCC ID: X7902684 Applicant: Correspondence Number: 731 Confirmation Number: Date of Original E-Mail: Otsuka America Pharmaceutical, Inc. 552515 TC174727 04/08/2023 Subject: Attestation letters required Please provide 3 attestation letters(Applicant, Agent and Equipment) with required language signed by both Applicant and Agent, place them in Attestation exhibits folder and not in Cover letter exhibits The items indicated above must be submitted before processing can continue on the above referenced application. Failure to provide the requested information within 30 days of the original e-mail date may result in application dismissal pursuant to Section 2.917(c). DO NOT Reply to this email by using the Reply button. In order for your response to be processed expeditiously, you must upload your response via the Internet at https://apps.fcc.gov/tcb, TCB Login, Submit Correspondence. Also, please note that partial responses increase processing time and should not be submitted. Any questions about the content of this correspondence should be directed to the e-mail address listed below the name of the sender.Acrobat Distiller 11.0 (Windows)